Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I single ascending dose study of T-4288 (solithromycin) in healthy adults
jRCT2080222225Phase 1
- Sponsor
- Fujifilm
- Start
- Sep 2013
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Gram-positive bacterial infection and mycoplasma infection comparing Solithromycin arm with Placebo arm (2 arms).
02
Drugs
solithromycin
03
Conditions
Gram-positive bacterial infectionmycoplasma infection
Beyond the preview
Go deeper on jRCT2080222225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222225.